PRESSURE BIOSCIENCES INC
DelistedCIK 830656fmd_19ZJ5MCN0M7WDPXGCNAW3QVXE9Manufacturing · Laboratory Analytical InstrumentsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2024, 57 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 1 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Cost of revenue | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 |
| Gross profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | (0) | 1 |
| Realized investment gains (losses) | – | – | – | – | – | – | 1 | (0) | – | – |
| Research and development | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Selling, general and administrative | 3 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 9 |
| Total operating expenses | 5 | 5 | 6 | 7 | 7 | 8 | – | – | – | – |
| Operating income | (3) | (4) | (4) | 91 | (4) | (6) | (5) | (4) | (5) | (10) |
| Interest expense | 1 | 4 | 5 | 6 | 4 | 5 | 8 | 14 | 10 | 16 |
| Interest and investment income | (1) | – | – | – | – | – | – | – | – | – |
| Other non-operating income (expense) | (1) | (4) | 1 | (6) | (5) | (6) | (11) | (16) | (11) | (20) |
| Income before taxes | – | – | – | – | – | – | – | – | – | – |
| Income tax expense | – | – | – | – | – | (0) | – | – | – | – |
| Net income from continuing operations | – | – | – | – | – | – | – | – | – | – |
| Net income | (5) | (7) | (3) | (11) | (10) | (12) | (16) | (20) | (16) | (7) |
| Net income to common shareholders | (6) | (7) | (3) | (11) | (23) | (16) | (18) | (23) | (18) | (35) |